To continue reading this content, please enable JavaScript in your browser settings and refresh this page. John Meehan and his wife, Mary Ellen, moved to Charlotte ...

HOUSTON, Oct. 16, 2025 /PRNewswire/ -- Oncologists and pharmacy experts are reacting to last week's Food and Drug Administration warning that requires genetic testing on patients receiving the common ...

An increasing number of clinically relevant association between drug response and genomic variation has been reported over the past years, resulting in evidence-based pharmacogenetic guidelines [1, 2] ...

In this free webinar, see how DPYD testing can be implemented from guidelines to go-live through practical pharmacogenomics (PGx) reporting and workflow design. The featured speakers will share ...

Pharmacogenetics enables personalization of drug therapy based on an individual’s genetic profile. Despite clinical relevance, implementation of pharmacogenetics remains limited. In Italy, integration ...

Pharmacogenetics (PGx)—how an individual's genetics influence treatment outcomes—has been a promising area of research for decades. Despite its potential to improve care and reduce cost, PGx has moved ...

IRVING, Texas, March 24, 2026 /PRNewswire/ -- Caris Life Sciences® (NASDAQ: CAI), a leading patient-centric, next-generation AI TechBio company and precision medicine pioneer, is recognizing ...

National clinical guidelines don’t mention screening cancer patients for DPYD gene variants, but hospital pharmacy leaders are forging ahead with the patient safety practice, the American Society of ...

A man in his early 70s died after adjuvant chemotherapy due to fulminant gastrointestinal toxicity and bowel ischaemia linked to an undetected dihydropyrimidine dehydrogenase (DPYD) deficiency, ...

IRVING, Texas, March 24, 2026 /PRNewswire/ -- Caris Life Sciences ® (NASDAQ: CAI), a leading patient-centric, next-generation AI TechBio company and precision medicine pioneer, is recognizing ...

Automatic pharmacogenomic testing provided on liquid biopsy: Access, prevalence, and integration in a safety net population. This is an ASCO Meeting Abstract from the 2026 ASCO Annual Meeting I. This ...